EurekaMag.com logo
+ Translate

Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention


, : Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. Annals of Epidemiology 2(3): 295-310

Phase I of the Trials of Hypertension Prevention was designed to test the effectiveness and safety of three life-style (weight loss, sodium restriction, and stress management) and four nutrition supplement (calcium, magnesium, potassium, and fish oil) interventions in reducing diastolic blood pressure (DBP) in persons with a high-normal blood pressure. A total of 2182 persons with a DBP between 80 and 89 mm Hg met the eligibility criteria for participation in phase I and were randomized to one of the active intervention or control treatment groups. Most were white (82%), male (70%), married (76%), nonsmoking (88%), college graduate (53%), full-time employees (91%). The average blood pressure prior to entry into the trial was 124.9 mm Hg systolic and 83.8 mm Hg diastolic. A variety of baseline observations, including sociodemographic characteristics, personal and family medical history, health habits, diet, and biologic measurements, were documented before randomization and compared among the seven active intervention and control groups. As might be expected in a randomized trial of this sample size, the distribution of measured baseline characteristics was virtually identical in the treated and control groups. Based on this finding and the knowledge that randomization procedures were implemented without deviation from the phase I protocol, it is probable that unknown potential confounders were also equally distributed at entry into the study. Given the achievement of high rates of follow-up, subsequent differences in blood pressure are unlikely to have been due to baseline differences between the active treatment and control groups, and can probably be attributed to effects of the active interventions.

Accession: 002308363

PMID: 1342280

DOI: 10.1016/1047-2797(92)90062-U

Download PDF Full Text: Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Whelton, P.K.; Hebert, P.R.; Cutler, J.; Applegate, W.B.; Eberlein, K.A.; Klag, M.J.; Keough, M.E.; Hamill, S.; Borhani, N.O.; Hollis, J., 1992: Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. Phase I of the Trials of Hypertension Prevention was designed to test the effectiveness and safety of three life-style (weight loss, sodium restriction, and stress management) and four nutrition supplement (calcium, magnesium, potassium, and fish...

Appel, L., J.; Hebert, P., R.; Cohen, J., D.; Obarzanek, E.; Yamamoto, M.; Buring, J.; Stevens, V.; Kirchner, K.; Borhani, N., O., 1995: Baseline characteristics of participants in phase II of the trials of hypertension prevention (TOHP II). Phase II of the Trials of Hypertension Prevention (TOHP II) is a multicenter, controlled clinical trial designed to test whether weight loss, a reduced sodium intake, or a combination of weight loss and a reduced sodium intake will lower blood pre...

Appel, L.J.; Hebert, P.R.; Cohen, J.D.; Obarzanek, E.; Yamamoto, M.; Buring, J.; Stevens, V.; Kirchner, K.; Borhani, N.O., 1995: Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Phase II of the Trials of Hypertension Prevention (TOHP II) is a multicenter, controlled clinical trial designed to test whether weight loss, a reduced sodium intake, or a combination of weight loss and a reduced sodium intake will lower blood pre...

Thompson, P.; Roe, D.J.; Fales, L.; Buckmeier, J.; Wang, F.; Hamilton, S.R.; Bhattacharyya, A.; Green, S.; Hsu, C-Hsieh.; Chow, H-H.Sherry.; Ahnen, D.J.; Boland, C.Richard.; Heigh, R.I.; Fay, D.E.; Martinez, M.Elena.; Jacobs, E.; Ashbeck, E.L.; Alberts, D.S.; Lance, P., 2013: Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. COX inhibitors reduce colorectal adenoma recurrence by up to 45% and selenium supplementation may prevent colorectal cancer. Following colonoscopic adenoma resection, 1,600 men and women, ages 40 to 80 years, were randomized to celecoxib (400 mg d...

Hall W.D.; Davis B.R.; Frost P.; Hoffmeier M.; O'brien J.E.; Pace S.; Page L.; Schneider K.A.; Stamler J., 1991: Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 7 baseline laboratory characteristics. Hypertension (Dallas) 17(3 SUPPL 2): II102-II122

Black H.R.; Unger D.; Burlando A.; Wright J.C.; Pressel S.L.; Allen R.; Mcdonald R.H.; Surath H., 1991: Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 6 baseline physical examination findings. Hypertension (Dallas) 17(3 SUPPL 2): II77-II101

Curb J.D.; Lee M.; Jensen J.; Applegate W., 1991: Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 4 baseline medical history findings. Hypertension (Dallas) 17(3 SUPPL 2): II35-II61

Hollis, J.F.; Satterfield, S.; Smith, F.; Fouad, M.; Allender, P.S.; Borhani, N.; Charleston, J.; Hirlinger, M.; King, N.; Schultz, R., 1995: Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Phase II of the Trials of Hypertension Prevention is a multicenter, randomized, controlled trial designed to determine the efficacy of weight loss and reduction of sodium intake for lowering blood pressure and incidence of hypertension among perso...

Labarthe D.R.; Blaufox M.D.; Smith W.M.; Lacy C.R.; Schnaper H.; Labaw F.; Mascioli S.; Davey J.; Lakatos E., 1991: Systolic hypertension in the elderly program shep baseline characteristics of the randomized shep participants part 5 baseline blood pressure and pulse rate measurements. Hypertension (Dallas) 17(3 SUPPL 2): II62-II76

Lasser, V.I.; Raczynski, J.M.; Stevens, V.J.; Mattfeldt-Beman, M.K.; Kumanyika, S.; Evans, M.; Danielson, E.; Dalcin, A.; Batey, D.M.; Belden, L.K., 1995: Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Identifying effective, nonpharmacologic means of preventing or significantly delaying the onset of hypertension would be a major advance in the primary prevention of cardiovascular disease. In the first phase of the Trials of Hypertension Preventi...